TORMID-Plus 5/10/20 contains Torsemide with spironolactone, which gives a maximal natriuretic than any other drug. The drug remains active even in patients with relatively severe renal failure. Its bioavailability is between 80 to 100%. It is superior to furosemide in relieving CHF symptoms. Overall it is a good product to reduce hospitalization rates.